Nucleic acid therapeutics in cancer
By: edited by Alan M. Gewirtz.
Contributors: Gewirtz, A. M.
Series: Cancer drug discovery and development
Publisher: Humana Press
Published: 2004
Place of publication: Totowa, N.J
Language: eng
Number of pages: 219
Subjects: Antisense nucleic acids -- Therapeutic use.; Cancer -- Chemotherapy.; Neoplasms -- therapy -- Congresses.; Gene Therapy -- methods -- Congresses.; Nucleic Acids -- therapeutic use -- Congresses.
Genres: Congresses.
Notes: Papers from a conference held Apr. 2000 in Bryn Mawr, Pa.

Includes bibliographical references and index.
Table of contents: value: Antisense methodology / Fritz Eckstein; value: Nucleic acid therapeutics / Alan M. Gewirtz; value: Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer; value: Therapeutic applications of ribozymes / John J. Rossi; value: Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun; value: Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga; value: Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael; value: The transport of oligonucleotides into cells / R.L. Juliano; value: Peptide-mediated delivery of antisense oligonucleotides and related material / Eric Vivås, Jean Philippe Richard and Bernard Lebleu; value: Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.]; value: Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel; value: Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz; value: Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline; value: LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.]; value: Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung.